Skip to main content
All lobbying filings

S-3 GROUP

Lobbying for FRESENIUS KABI · Healthcare/pharmaceutical company

 Filing Registration
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · posted Feb 7, 2025

Official filing document

 Lobbying activity 2
Health Issues

Issues related to drug pricing legislation, biosimilars, patent reform, rebate reform, electronic labeling and FDA Foreign Inspection backlog

Copyright/Patent/Trademark

Issues related to drug pricing legislation, biosimilars, patent reform, rebate reform, electronic labeling and FDA Foreign Inspection backlog

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem